Sparrow Pharmaceuticals

Drug DiscoveryWebsite

Operator of a cardiometabolic therapeutics platform intended to address treatment-resistant diabetes and related metabolic conditions. The company offers a novel oral hydroxysteroid dehydrogenase type...

Drug Discovery
Healthcare
Portland, OR, United States
Founded 2013
10 employees
Website
Valuation
$139M
Market implied
Share Price
N/A
Total Raised
$145.8M
Last Round
Later Stage VC (Series B)
Sep 2025
Latest Funding Round
Later Stage VC (Series B)
Sep 24, 2025
$95M
raised
View all funding rounds
Investors
+11 other investors
View all 11 investors
Valuation History
1 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock Sparrow Pharmaceuticals's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required